arrow
Back
I

I.D. Davis

australian & new zealand urogenital & prostate cancer trials group

7H-index
22Paper Count
307Citation Count
Published Papers 3
Publication Date
Clinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304)
err2024-09-01
err0
PREAI
errHamid, A. A.; Thomas, H.; Martin, A.; Soon, Y. Y.; Horvath, L. G.; Zielinski, R.; Thomson, A.; Tan, H.; Sandhu, S. K.; Reaume, M. N.; Pook, D. W.; Parnis, F.; McDermott, R. S.; Lawrence, N.; Frydenberg, M.; Chi, K. N.; Stockler, M. R.; Davis, I. D.; Sweeney, C.
errShare
errSave
Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile?
err2018-02-01
err12
errOAAI
errBlinman, P. L.; Davis, I. D.; Martin, A.; Troon, S.; Sengupta, S.; Hovey, E.; Coskinas, X.; Kaplan, R.; Ritchie, A.; Meade, A.; Eisen, T.; Stockler, M. R.
errShare
errSave
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
err2017-08-01
err4
errOAAI
errPezaro, C. J.; Omlin, A.; Mastris, K.; Attard, G.; Beer, T. M.; Chi, K. N.; Chowdhury, S.; Davis, I. D.; Drake, C. G.; de Bono, J. S.; Efstathiou, E.; Gravis, G.; Higano, C. S.; Hussain, M.; James, N.; Logothetis, C. J.; Morgans, A.; Parker, C.; Ryan, C. J.; Saad, F.; Sartor, O.; Small, E. J.; Sternberg, C. N.; Sweeney, C. J.; Tannock, I.; Tombal, B.; Gillessen, S.
errShare
errSave